Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like Ignyta To Present At 2016 Healthcare Conference July 8, 2016 <b>Spruce Biosciences</b> Provides Corporate Update On Series A Venture Financing, Leadership Team And Lead Clinical Program October 11, 2017 On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma November 16, 2017
<b>Spruce Biosciences</b> Provides Corporate Update On Series A Venture Financing, Leadership Team And Lead Clinical Program October 11, 2017
